Document Detail

The role of surgical resection in the management of brain metastasis: a 17-year longitudinal study.
MedLine Citation:
PMID:  23325516     Owner:  NLM     Status:  Publisher    
BACKGROUND: Advancements over the past generation have yielded several new treatment options for the management of brain metastases. However, surgical resection (SR) still remains the mainstay of treatment and is performed especially if decompression is required. The goal of this study was to evaluate the role of surgical resection for patients with brain metastases and to find the best indications for SR. METHODS: SR as an initial treatment was performed in 157 patients. Among the 157 patients, 109 (69.4 %) and 17 (10.8 %) underwent adjuvant whole-brain radiotherapy and radiosurgery, respectively. Thirty-one (19.7 %) patients did not undergo adjuvant treatment. Overall survival, tumour recurrence, and clinical outcomes were evaluated. The clinical situation was classified based on the recursive partitioning analysis (RPA) class and Karnofsky performance scale (KPS). RESULTS: The overall median survival was 19.3 months. Median survival according to the extent of surgical resection was 20.4 months after gross total resection (GTR) and 15.1 months after subtotal resection (STR) (P = 0.016). The patients with stable primary extracranial cancer survived longer than patients with synchronous detection of extracranial cancer (P = 0.032). The RPA I class patients showed longer survival than the RPA II class patients (P = 0.047). This difference was more prominent in the GTR group than in the STR group (GTR, P = 0.022; STR, P = 0.075). The KPS score of the GTR group changed from 82.3 to 87.0 and that of the STR group changed from 79.2 to 77.1 (P = 0.001). Adjuvant treatment did not lead to a significant improvement in the survival and clinical outcome. CONCLUSIONS: Surgical resection may accomplish satisfactory outcomes with technical advancement. The best indications for SR for brain metastasis are RPA I class, stable extracranial cancer, and a planned GTR of the tumour. Even with the advancements in adjuvant therapy, surgical resection plays a major role in the management of brain metastasis.
Chang-Hyun Lee; Dong Gyu Kim; Jin Wook Kim; Jung Ho Han; Yong Hwy Kim; Chul-Kee Park; Chae-Yong Kim; Sun Ha Paek; Hee-Won Jung
Related Documents :
7500656 - Calla positive acute lymphoblastic leukemia after etoposide-based therapy for ewing's s...
24952906 - The impact of isolated tumor cells on loco-regional recurrence in breast cancer patient...
6954996 - Association between hla-d region antigens and disease-free survival in childhood non-t,...
24953266 - A comparison of colorectal cancer in nigerian and north american patients: is the cance...
25105406 - A modified duodenal neuroendocrine tumor staging schema better defines the risk of lymp...
11389706 - Allogeneic bone marrow transplantation for chronic myeloid leukemia: a retrospective st...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-17
Journal Detail:
Title:  Acta neurochirurgica     Volume:  -     ISSN:  0942-0940     ISO Abbreviation:  Acta Neurochir (Wien)     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0151000     Medline TA:  Acta Neurochir (Wien)     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Neurosurgery, Seoul National University Bundang Hospital, Seongnam, South Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Health-related quality of life at median 12 months after aneurysmal subarachnoid hemorrhage, measur...
Next Document:  Synthesis and Antioxidant Activity of a New Class of Mono- and Bis-Heterocycles.